Design and characterization of a novel structural class of Kv1.3 inhibitors
Authorized Users Only
AuthorsHendrickx, Louise Antonia
Peterlin Mašič, Lucija
Article (Published version)
MetadataShow full item record
The voltage-gated potassium channel Kv1.3 is involved in multiple autoimmune diseases, such as multiple sclerosis, rheumatoid arthritis, diabetes mellitus type 1 and psoriasis. In many auto-immune diseases better treatment options are desired as existing therapies are often ineffective or become less effective over time, for which Kv1.3 inhibitors arise as promising candidates. In this study, five compounds were selected based on a 3D similarity searching methodology and subsequently screened ex vivo on the Kv1.3 channel. The screening resulted in two compounds inhibiting the Kv1.3 channel, of which TVS-12 was the most potent compound, while TVS-06 -although less potent- showed an excellent selectivity for Kv1.3. For both compounds the mechanism of action was investigated by an electrophysiological characterization on the Kv1.3 channel and three Kv1.3 mutants, designed to resemble the pore region of Kv1.2 channels. Structurally, the presence of a benzene ring and/or an oxane ring seems... to cause a better interaction with the Kv1.3 channel, resulting in a 20-fold higher potency for TVS-12.
Source:Bioorganic Chemistry, 2020, 98
- Slovenian Research Agency (Grant No. P1-0208, J1-9192 and N1-0098)
- JT was funded by GOC2319 N and GOA4919 N (F.W.O.Vlaanderen)andCELSA/17/047(BOF,KULeuven)
- SPissupportedbyKU Leuven funding (PDM/19/164).